Damian J. Krysan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Damian J. Krysan has a total of 351 co-authors. Here are the top co-authors by number of shared publications:
Rohan S. Wakade
Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
21 shared publicationsMelanie Wellington
Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
19 shared publicationsLouis DiDone
Department of Pediatrics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, United States
16 shared publicationsSarah R. Beattie
Department of Pediatrics, Carver College of Medicine
13 shared publicationsAndrew J. Jezewski
Affiliation Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, lowa, United States of America
12 shared publications- Melanie Wellington
Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA
12 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (10) , e0205126
The RNA-binding protein Psc1 functions downstream of the NDR/LATS kinase Cbk1 to modulate CO 2 tolerance in Cryptococcus neoformans
Cryptococcus neoformans is an opportunistic fungal pathogen responsible for approximately 20% of deaths in patients with HIV/AIDS. Adaptation to host physiological conditions, including high CO 2 , is required for infection. We discovered that an uncharacterized protein with an RNA-binding domain, Psc1, functions as a basidiomycete-specific suppressor of the kinase mutant cbk1 Δ and partially rescues its growth defect in high CO 2 . Psc1 contains multiple consensus c ell wall b iosynthesis k inase 1 (Cbk1) phosphorylation sites that are required for maintenance of CO 2 fitness. We hypothesized that, in the absence of Cbk1, Psc1 negatively regulates CO 2 tolerance by binding to and interfering with the function of mRNAs required for CO 2 tolerance. Supporting this model, we found that multiple mRNAs that are required for CO 2 tolerance associate with Psc1 in the absence of Cbk1. Furthermore, the transcripts of ZDS3 , a gene required for CO 2 tolerance, predominantly colocalize with Psc1, which forms condensates in the cbk1 Δ mutant at high CO 2 , correlating with impaired growth. Collectively, our findings support the conclusion that C. neoformans adapts to high CO 2 through a post-transcriptional mechanism where Cbk1 phosphorylates Psc1, preventing its binding to, and subsequent functional inhibition of, mRNAs important for CO 2 tolerance. IMPORTANCE: High CO 2 is growth-inhibitory, and therefore adaptation to high CO 2 stress is a universal cellular phenomenon required for survival. The environmental fungus, Cryptococcus neoformans , encounters high CO 2 environments in the host, and thus tolerance to high CO 2 is critical for its ability to cause lethal infections. The regulation of A ce2p and morphogenesis (RAM) pathway is required for its growth in high CO 2 . We found that CO 2 tolerance is mediated post-transcriptionally by a downstream target of the RAM pathway, the RNA-binding protein Psc1. In the absence of the RAM pathway, Psc1 sequesters mRNA transcripts required for growth in high CO 2 , preventing growth. These findings reveal a previously uncharacterized post-transcriptional regulatory mechanism that controls cryptococcal adaptation to high CO 2 .
- 14 October 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (10) , e0205126
Open AccessThe RNA-binding protein Psc1 functions downstream of the NDR/LATS kinase Cbk1 to modulate CO 2 tolerance in Cryptococcus neoformans
Cryptococcus neoformans is an opportunistic fungal pathogen responsible for approximately 20% of deaths in patients with HIV/AIDS. Adaptation to host physiological conditions, including high CO 2 , is required for infection. We discovered that an uncharacterized protein with an RNA-binding domain, Psc1, functions as a basidiomycete-specific suppressor of the kinase mutant cbk1 Δ and partially rescues its growth defect in high CO 2 . Psc1 contains multiple consensus c ell wall b iosynthesis k inase 1 (Cbk1) phosphorylation sites that are required for maintenance of CO 2 fitness. We hypothesized that, in the absence of Cbk1, Psc1 negatively regulates CO 2 tolerance by binding to and interfering with the function of mRNAs required for CO 2 tolerance. Supporting this model, we found that multiple mRNAs that are required for CO 2 tolerance associate with Psc1 in the absence of Cbk1. Furthermore, the transcripts of ZDS3 , a gene required for CO 2 tolerance, predominantly colocalize with Psc1, which forms condensates in the cbk1 Δ mutant at high CO 2 , correlating with impaired growth. Collectively, our findings support the conclusion that C. neoformans adapts to high CO 2 through a post-transcriptional mechanism where Cbk1 phosphorylates Psc1, preventing its binding to, and subsequent functional inhibition of, mRNAs important for CO 2 tolerance. IMPORTANCE: High CO 2 is growth-inhibitory, and therefore adaptation to high CO 2 stress is a universal cellular phenomenon required for survival. The environmental fungus, Cryptococcus neoformans , encounters high CO 2 environments in the host, and thus tolerance to high CO 2 is critical for its ability to cause lethal infections. The regulation of A ce2p and morphogenesis (RAM) pathway is required for its growth in high CO 2 . We found that CO 2 tolerance is mediated post-transcriptionally by a downstream target of the RAM pathway, the RNA-binding protein Psc1. In the absence of the RAM pathway, Psc1 sequesters mRNA transcripts required for growth in high CO 2 , preventing growth. These findings reveal a previously uncharacterized post-transcriptional regulatory mechanism that controls cryptococcal adaptation to high CO 2 .
- Open Access
- 12 August 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (8) , e0149226
The transcription factor Ahr1 governs the recruitment of neutrophils to the brain and clearance of Candida albicans during CNS infection
Candida albicans causes infections of the central nervous system in premature infants and people with primary immune deficiencies affecting the innate immune system. Compared to infections in other organs, the pathogenesis and host responses to C. albicans brain infections are understudied. However, the CARD9/NLRP3/interleukin 1 (IL-1) axis has been shown to play a central role in protecting the brain from C. albicans through the recruitment of neutrophils. In addition, Ece1/candidalysin is a key fungal trigger of this pathway in the brain. Here, we demonstrate that the transcription factor Ahr1 is also required for the activation of the NLRP3/IL-1β axis, recruitment of neutrophils, and clearance of C. albicans from the brain. In contrast to its function in vitro , Ahr1 does not govern the expression of ECE1 in infected brain tissue. While our data show that Ahr1 and Ece1 have overlapping effects on the NLRP3/IL-1 axis, we have also observed clear distinctions in their function with respect to chemokine secretion. Our data support a model in which Ahr1 is required for the first priming step of NLRP3 inflammasome assembly, leading to IL-1β production. Ece1/candidalysin, on the other hand, plays an important role in driving both the second step of NLRP3 inflammasome activation and the inflammasome-independent IL-1α-mediated responses to C. albicans brain infection. IMPORTANCE: Candida albicans infections of the brain can cause devastating consequences, particularly for premature infants. However, C. albicans infection of the brain has been understudied relative to other types of infection. We have found that the regulator of gene expression Ahr1 governs the expression of C. albicans factors that are recognized by the host and which drive the influx of neutrophils to the brain. This process is critical to the clearance of the fungus from the brain. Our data also suggest that these Ahr1-dependent factors are required to prime this immune response and function at a different step compared to the toxin candidalysin, a protein that is also required for the host to clear C. albicans from the brain.
- 12 August 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (8) , e0149226
Open AccessThe transcription factor Ahr1 governs the recruitment of neutrophils to the brain and clearance of Candida albicans during CNS infection
Candida albicans causes infections of the central nervous system in premature infants and people with primary immune deficiencies affecting the innate immune system. Compared to infections in other organs, the pathogenesis and host responses to C. albicans brain infections are understudied. However, the CARD9/NLRP3/interleukin 1 (IL-1) axis has been shown to play a central role in protecting the brain from C. albicans through the recruitment of neutrophils. In addition, Ece1/candidalysin is a key fungal trigger of this pathway in the brain. Here, we demonstrate that the transcription factor Ahr1 is also required for the activation of the NLRP3/IL-1β axis, recruitment of neutrophils, and clearance of C. albicans from the brain. In contrast to its function in vitro , Ahr1 does not govern the expression of ECE1 in infected brain tissue. While our data show that Ahr1 and Ece1 have overlapping effects on the NLRP3/IL-1 axis, we have also observed clear distinctions in their function with respect to chemokine secretion. Our data support a model in which Ahr1 is required for the first priming step of NLRP3 inflammasome assembly, leading to IL-1β production. Ece1/candidalysin, on the other hand, plays an important role in driving both the second step of NLRP3 inflammasome activation and the inflammasome-independent IL-1α-mediated responses to C. albicans brain infection. IMPORTANCE: Candida albicans infections of the brain can cause devastating consequences, particularly for premature infants. However, C. albicans infection of the brain has been understudied relative to other types of infection. We have found that the regulator of gene expression Ahr1 governs the expression of C. albicans factors that are recognized by the host and which drive the influx of neutrophils to the brain. This process is critical to the clearance of the fungus from the brain. Our data also suggest that these Ahr1-dependent factors are required to prime this immune response and function at a different step compared to the toxin candidalysin, a protein that is also required for the host to clear C. albicans from the brain.
- Open Access
- 5 May 2026
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 24 (5) , e3003561
Cryptococcus neoformans adapts to host CO2 concentrations via metabolic and stress-response remodeling
Cryptococcus neoformans is an environmental pathogen that remodels its cellular physiology to survive within mammals and, in susceptible hosts, cause life-threatening meningoencephalitis. Of the many distinctions between the external environment and mammalian tissues, CO 2 concentration in the host is two orders of magnitude higher than in the environment and represents a critical stress for C. neoformans . C. neoformans strains that do not replicate at host CO 2 concentrations are less virulent in mouse models of infection, further supporting CO 2 tolerance as a virulence trait. To further understand the genetic determinants of C. neoformans CO 2 tolerance, we performed a near genome-wide screen for deletion mutants with altered CO 2 fitness using a competitive growth assay. A total of 301 of 4,692 deletion mutants showed altered CO 2 tolerance (245 reduced fitness; 56 increased fitness) demonstrating the global effect of host CO 2 on C. neoformans physiology. Based on this data set as well as a metabolomic analysis of C. neoformans adaptation to host CO 2 , we show that remodeling of central carbon metabolism, oxidative stress buffering, and membrane homeostasis represent an integrated response to CO 2 stress that is mediated in part by the TOR-Ypk1 signaling axis. We propose that CO 2 -induced capsule formation leads to reduced cellular glucose which, in turn, triggers remodeling of central carbon metabolism toward utilization of alternative carbon sources and increased mitochondrial respiration/reactive oxygen generation. Thus, these data provide a near genome-wide profile of the genetic determinants of C. neoformans CO 2 tolerance as well as a model for how this important environmental human fungal pathogen alters its physiology to proliferate in the host.
- 5 May 2026
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 24 (5) , e3003561
Open AccessCryptococcus neoformans adapts to host CO2 concentrations via metabolic and stress-response remodeling
Cryptococcus neoformans is an environmental pathogen that remodels its cellular physiology to survive within mammals and, in susceptible hosts, cause life-threatening meningoencephalitis. Of the many distinctions between the external environment and mammalian tissues, CO 2 concentration in the host is two orders of magnitude higher than in the environment and represents a critical stress for C. neoformans . C. neoformans strains that do not replicate at host CO 2 concentrations are less virulent in mouse models of infection, further supporting CO 2 tolerance as a virulence trait. To further understand the genetic determinants of C. neoformans CO 2 tolerance, we performed a near genome-wide screen for deletion mutants with altered CO 2 fitness using a competitive growth assay. A total of 301 of 4,692 deletion mutants showed altered CO 2 tolerance (245 reduced fitness; 56 increased fitness) demonstrating the global effect of host CO 2 on C. neoformans physiology. Based on this data set as well as a metabolomic analysis of C. neoformans adaptation to host CO 2 , we show that remodeling of central carbon metabolism, oxidative stress buffering, and membrane homeostasis represent an integrated response to CO 2 stress that is mediated in part by the TOR-Ypk1 signaling axis. We propose that CO 2 -induced capsule formation leads to reduced cellular glucose which, in turn, triggers remodeling of central carbon metabolism toward utilization of alternative carbon sources and increased mitochondrial respiration/reactive oxygen generation. Thus, these data provide a near genome-wide profile of the genetic determinants of C. neoformans CO 2 tolerance as well as a model for how this important environmental human fungal pathogen alters its physiology to proliferate in the host.
- Open Access
- 14 April 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (16) , 24237-24249
Optimization of Antifungal 1,5-Diaryl-Pyrazole Acetyl-CoA Synthetase Inhibitors
Acetyl-CoA Synthetases (ACS) have emerged as a potential drug target for the treatment of diseases ranging from fungal and parasitic infections to cancer and hyperlipidemia. While species-selective ACS inhibitors have been reported, broad-spectrum inhibition of ACS enzymes has only been achieved with nucleoside-derived, bisubstrate analogs such as alkyl esters of adenosine monophosphate (AMP). Previously, we identified the diaryl pyrazole AR-12 as a non-nucleoside inhibitor of S. cerevisiae ACS with broad-spectrum antifungal activity. In this study, we undertook a medicinal-chemistry approach to optimize the AR-12 scaffold with the goals of improving its pharmacology and activity against ACS enzymes from human fungal pathogens such as Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus. These efforts have led to the improved on-target activity for a set of analogs against multiple fungal enzymes. We identified key substituents that are critical determinants of the ACS inhibition displayed by this diaryl pyrazole class of inhibitors. Modeling and molecular dynamics calculations also indicate that these improved molecules likely bind in the same region of the ACS active site in which the alkyl-AMP esters bind. Finally, the most active diaryl pyrazole has improved mammalian cytotoxicity and pharmacology relative to AR-12. However, additional optimization of this class of ACS inhibitors will be needed to generate a molecule with efficacy in preclinical animal models.
- 14 April 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (16) , 24237-24249
Open AccessOptimization of Antifungal 1,5-Diaryl-Pyrazole Acetyl-CoA Synthetase Inhibitors
Acetyl-CoA Synthetases (ACS) have emerged as a potential drug target for the treatment of diseases ranging from fungal and parasitic infections to cancer and hyperlipidemia. While species-selective ACS inhibitors have been reported, broad-spectrum inhibition of ACS enzymes has only been achieved with nucleoside-derived, bisubstrate analogs such as alkyl esters of adenosine monophosphate (AMP). Previously, we identified the diaryl pyrazole AR-12 as a non-nucleoside inhibitor of S. cerevisiae ACS with broad-spectrum antifungal activity. In this study, we undertook a medicinal-chemistry approach to optimize the AR-12 scaffold with the goals of improving its pharmacology and activity against ACS enzymes from human fungal pathogens such as Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus. These efforts have led to the improved on-target activity for a set of analogs against multiple fungal enzymes. We identified key substituents that are critical determinants of the ACS inhibition displayed by this diaryl pyrazole class of inhibitors. Modeling and molecular dynamics calculations also indicate that these improved molecules likely bind in the same region of the ACS active site in which the alkyl-AMP esters bind. Finally, the most active diaryl pyrazole has improved mammalian cytotoxicity and pharmacology relative to AR-12. However, additional optimization of this class of ACS inhibitors will be needed to generate a molecule with efficacy in preclinical animal models.
- Open Access
- 10 December 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (12) , e0291325
The Candida albicans transcription factor Efg1 governs hyphal morphogenesis independently of the cAMP-protein kinase A pathway
Candida albicans is one of the most common causes of human fungal disease. An intensively studied C. albicans virulence traits is its ability to adopt both yeast and filamentous morphologies. Accordingly, the regulation of the yeast-to-filament transition has been an area of intense study in medical mycology. A long-standing mechanistic paradigm in this field is that the cAMP-protein kinase A pathway phosphorylates a master transcriptional regulator of C. albicans filamentation, Efg1, to drive filamentation. This model has been generalized over the years despite the fact that the initial work showed that it applied to only specific in vitro filamentation conditions. Here, we reinvestigated the protein kinase A-Efg1 paradigm by generating new strains containing alleles of EFG1 with the putative protein kinase A phosphorylation site (T208) mutated to either Ala or Glu which blocks or mimics phosphorylation, respectively. We integrated these alleles into efg1 ∆∆ mutants so that they are expressed from the endogenous promoter. We assayed the effect of these Efg1 mutations on (i) in vitro filamentation under a wide range of inducing conditions, (ii) biofilm formation, (iii) in vivo filamentation, (iv) virulence in a model of disseminated candidiasis, and (v) gene expression during in vitro filamentation. Using updated genetic approaches, we found no evidence that blocking or mimicking protein kinase phosphorylation of Efg1 affected its function during filamentation, biofilm formation, or infection. Therefore, additional studies will be required to identify the mechanisms by which Efg1 is regulated during hyphal morphogenesis. IMPORTANCE: Candida albicans is a common human fungal pathogen causing both superficial mucosal and life-threatening invasive disease. The virulence of C. albicans is associated with its ability to form filamentous hyphae and pseudohyphae. The regulation of this process is widely attributed to the phosphorylation of a transcription factor Efg1 by the protein kinase A signaling pathway. Since its initial description 25 years ago, this model has informed the design and interpretation of many studies of C. albicans . Through the use of updated genetic methods, we have found that protein kinase A-mediated phosphorylation of Efg1 is dispensable for filamentation, biofilm formation, and virulence in an experimental model of candidiasis. Although these data are negative in nature, the centrality of the protein kinase A-Efg1 paradigm to C. albicans pathogenesis studies increases their impact and should catalyze new studies to understand how this master regulator of C. albicans biology is itself regulated.
- 10 December 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (12) , e0291325
Open AccessThe Candida albicans transcription factor Efg1 governs hyphal morphogenesis independently of the cAMP-protein kinase A pathway
Candida albicans is one of the most common causes of human fungal disease. An intensively studied C. albicans virulence traits is its ability to adopt both yeast and filamentous morphologies. Accordingly, the regulation of the yeast-to-filament transition has been an area of intense study in medical mycology. A long-standing mechanistic paradigm in this field is that the cAMP-protein kinase A pathway phosphorylates a master transcriptional regulator of C. albicans filamentation, Efg1, to drive filamentation. This model has been generalized over the years despite the fact that the initial work showed that it applied to only specific in vitro filamentation conditions. Here, we reinvestigated the protein kinase A-Efg1 paradigm by generating new strains containing alleles of EFG1 with the putative protein kinase A phosphorylation site (T208) mutated to either Ala or Glu which blocks or mimics phosphorylation, respectively. We integrated these alleles into efg1 ∆∆ mutants so that they are expressed from the endogenous promoter. We assayed the effect of these Efg1 mutations on (i) in vitro filamentation under a wide range of inducing conditions, (ii) biofilm formation, (iii) in vivo filamentation, (iv) virulence in a model of disseminated candidiasis, and (v) gene expression during in vitro filamentation. Using updated genetic approaches, we found no evidence that blocking or mimicking protein kinase phosphorylation of Efg1 affected its function during filamentation, biofilm formation, or infection. Therefore, additional studies will be required to identify the mechanisms by which Efg1 is regulated during hyphal morphogenesis. IMPORTANCE: Candida albicans is a common human fungal pathogen causing both superficial mucosal and life-threatening invasive disease. The virulence of C. albicans is associated with its ability to form filamentous hyphae and pseudohyphae. The regulation of this process is widely attributed to the phosphorylation of a transcription factor Efg1 by the protein kinase A signaling pathway. Since its initial description 25 years ago, this model has informed the design and interpretation of many studies of C. albicans . Through the use of updated genetic methods, we have found that protein kinase A-mediated phosphorylation of Efg1 is dispensable for filamentation, biofilm formation, and virulence in an experimental model of candidiasis. Although these data are negative in nature, the centrality of the protein kinase A-Efg1 paradigm to C. albicans pathogenesis studies increases their impact and should catalyze new studies to understand how this master regulator of C. albicans biology is itself regulated.
- Open Access
Cryptococcus neoformans adapts to host CO 2 concentrations through the coordinated remodeling of central carbon metabolism, oxidative stress resistance, and membrane homeostasis
Cryptococcus neoformans is an environmental pathogen that remodels its cellular physiology to survive within mammals and, in susceptible hosts, cause life-threatening meningoencephalitis. Of the many distinctions between the external environment and mammalian tissues, CO 2 concentration in the host is 2 orders of magnitude higher than in the environment and represent a critical stress for C. neoformans . C. neoformans strains that do not replicate at host CO 2 concentrations are less virulent in mouse models of infection, further supporting CO 2 tolerance as a virulence trait. To further understand the genetic determinants of C. neoformans CO 2 tolerance, we performed a near genome-wide screen for deletion mutants with altered CO 2 fitness using a competitive growth assay. A total of 301 of 4698 deletion mutants showed altered CO 2 tolerance (245 reduced fitness; 51 increased fitness) demonstrating the global effect of host CO 2 on C. neoformans physiology. Based on this data set as well as a metabolomic analysis of C. neoformans adaptation to host CO 2 , we show that remodeling of central carbon metabolism, oxidative stress buffering and membrane homeostasis represent an integrated response to CO 2 stress that is mediated in part by the TOR-Ypk1 signaling axis. We propose that CO 2 -induced capsule formation leads to reduced cellular glucose which, in turn, triggers remodeling of central carbon metabolism toward utilization of alternative carbon sources and increased mitochondrial respiration/reactive oxygen generation. Thus, these data provide a near genome-wide profile of the genetic determinants of C. neoformans CO 2 tolerance as well as a model for how this important environmental human fungal pathogen alters its physiology to proliferate in the host.
Open AccessCryptococcus neoformans adapts to host CO 2 concentrations through the coordinated remodeling of central carbon metabolism, oxidative stress resistance, and membrane homeostasis
Cryptococcus neoformans is an environmental pathogen that remodels its cellular physiology to survive within mammals and, in susceptible hosts, cause life-threatening meningoencephalitis. Of the many distinctions between the external environment and mammalian tissues, CO 2 concentration in the host is 2 orders of magnitude higher than in the environment and represent a critical stress for C. neoformans . C. neoformans strains that do not replicate at host CO 2 concentrations are less virulent in mouse models of infection, further supporting CO 2 tolerance as a virulence trait. To further understand the genetic determinants of C. neoformans CO 2 tolerance, we performed a near genome-wide screen for deletion mutants with altered CO 2 fitness using a competitive growth assay. A total of 301 of 4698 deletion mutants showed altered CO 2 tolerance (245 reduced fitness; 51 increased fitness) demonstrating the global effect of host CO 2 on C. neoformans physiology. Based on this data set as well as a metabolomic analysis of C. neoformans adaptation to host CO 2 , we show that remodeling of central carbon metabolism, oxidative stress buffering and membrane homeostasis represent an integrated response to CO 2 stress that is mediated in part by the TOR-Ypk1 signaling axis. We propose that CO 2 -induced capsule formation leads to reduced cellular glucose which, in turn, triggers remodeling of central carbon metabolism toward utilization of alternative carbon sources and increased mitochondrial respiration/reactive oxygen generation. Thus, these data provide a near genome-wide profile of the genetic determinants of C. neoformans CO 2 tolerance as well as a model for how this important environmental human fungal pathogen alters its physiology to proliferate in the host.
- 21 November 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 302 (Pt 3) , 118373
Second generation repurposing of phenothiazine antipsychotic drugs as antifungal lead molecules via optimization of phenoxazine derivatives
- 21 November 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 302 (Pt 3) , 118373
Second generation repurposing of phenothiazine antipsychotic drugs as antifungal lead molecules via optimization of phenoxazine derivatives
- Open Access
- 14 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Discovery and mechanism of a highly selective, antifungal acetyl-CoA synthetase inhibitor
Acetyl-CoA synthetases (Acs) have emerged as drug targets for the treatment of cancer, metabolic diseases as well as fungal and parasitic infections. Although a variety of small molecule Acs inhibitors have been discovered, the systematic optimization of these molecules has been slowed by a lack of structural information regarding their mechanism of inhibition. Through a chemical genetic-based, synthetic lethal screen of the human fungal pathogen Cryptococcus neoformans, we identified an isoxazole-based Acs inhibitor with antifungal activity and high selectivity for the C. neoformans Acs1 relative to human ACSS2 as well as to other fungal Acs enzymes. Xray crystallography of the isoxazole-CnAcs1 complex revealed that the isoxazole occupies both the acetyl- and CoA-binding sites of CnAcs1. Biochemically, the isoxazoles display uncompetitive inhibition kinetics that are similar to antimalarial Acs inhibitors also proposed to target the CoA binding site. Consequently, these data provide structural and mechanistic insights into the remarkable selectivity of CoA pocket-targeting Acs inhibitors. As such, targeting fungal and parasitic Acs enzymes for the development of novel anti-infectives can be achieved with high selectivity and, thereby, low host toxicity.
- 14 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Open AccessDiscovery and mechanism of a highly selective, antifungal acetyl-CoA synthetase inhibitor
Acetyl-CoA synthetases (Acs) have emerged as drug targets for the treatment of cancer, metabolic diseases as well as fungal and parasitic infections. Although a variety of small molecule Acs inhibitors have been discovered, the systematic optimization of these molecules has been slowed by a lack of structural information regarding their mechanism of inhibition. Through a chemical genetic-based, synthetic lethal screen of the human fungal pathogen Cryptococcus neoformans, we identified an isoxazole-based Acs inhibitor with antifungal activity and high selectivity for the C. neoformans Acs1 relative to human ACSS2 as well as to other fungal Acs enzymes. Xray crystallography of the isoxazole-CnAcs1 complex revealed that the isoxazole occupies both the acetyl- and CoA-binding sites of CnAcs1. Biochemically, the isoxazoles display uncompetitive inhibition kinetics that are similar to antimalarial Acs inhibitors also proposed to target the CoA binding site. Consequently, these data provide structural and mechanistic insights into the remarkable selectivity of CoA pocket-targeting Acs inhibitors. As such, targeting fungal and parasitic Acs enzymes for the development of novel anti-infectives can be achieved with high selectivity and, thereby, low host toxicity.
- Open Access
- 29 August 2025
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 129, 130389
Synthesis and evaluation of acyl-AMP phosphate isosteres as inhibitors of fungal acetyl CoA synthetase
- 29 August 2025
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 129, 130389
Open AccessSynthesis and evaluation of acyl-AMP phosphate isosteres as inhibitors of fungal acetyl CoA synthetase
- Open Access
- 8 August 2025
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (8) , e1013351
Host-induced climate change: Carbon dioxide tolerance as a Cryptococcus neoformans virulence trait
- 8 August 2025
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (8) , e1013351
Open AccessHost-induced climate change: Carbon dioxide tolerance as a Cryptococcus neoformans virulence trait